February 08 2022
Dr. Austin Miller was recently re-elected to serve a fourth three-year term as a Biostatistician on the National Cancer Institute (NCI) Uterine Task Force (UT). The UT is one of the 3 NCI/NCTN Gynecologic Task Forces and is composed of leading experts in uterine cancer trials and trial design. With this role on the NCI Uterine Task Force, he will continue to participate in meetings to review and make recommendations on phase 2 and 3 trial concepts focused on treatment of uterine cancers such as endometrial cancer, uterine carcinosarcoma and leiomyosarcoma, and gestational trophoblastic neoplasia.
Dr. Miller is the Associate Head of the Statistics Division of the NRG Statistics and Data Management Center (SDMC) and the Lead Statistician of the NRG Rare Tumor and Ovarian Tumor Subcommittees and is also a voting member of the Gynecologic Cancer Committee.Dr. Miller participates in the NRG Research Strategy Committee concept review meetings and is a reporting statistician on the NRG Data Monitoring Committee.Dr. Miller’s primary appointment is as Director of Biostatistics and Statistical Programming for the Clinical Trial Development Division of the Department of Biostatistics and Bioinformatics at Roswell Park Comprehensive Cancer Center.At Roswell Park, Dr. Miller also serves on the Scientific Review Committee and collaborates on studies run by GOG Partners.Dr. Miller also has a joint appointment at the University at Buffalo Biostatistics Department.His primary research interests include the design and analysis of experimental, clinical and observational studies, and measurement error models.